Dual-surface modified virus capsids for targeted delivery of photodynamic agents to cancer cells

Nicholas Stephanopoulos, Gary J. Tong, Sonny C. Hsiao, Matthew B. Francis

Research output: Contribution to journalArticle

135 Citations (Scopus)

Abstract

Bacteriophage MS2 was used to construct a targeted, multivalent photodynamic therapy vehicle for the treatment of Jurkat leukemia T cells. The self-assembling spherical virus capsid was modified on the interior surface with up to 180 porphyrins capable of generating cytotoxic singlet oxygen upon illumination. The exterior of the capsid was modified with ∼20 copies of a Jurkat-specific aptamer using an oxidative coupling reaction targeting an unnatural amino acid. The capsids were able to target and selectively kill more than 76% of the Jurkat cells after only 20 min of illumination. Capsids modified with a control DNA strand did not target Jurkat cells, and capsids modified with the aptamer were found to be specific for Jurkat cells over U266 cells (a control B cell line). The doubly modified capsids were also able to kill Jurkat cells selectively even when mixed with erythrocytes, suggesting the possibility of using our system to target blood-borne cancers or other pathogens in the blood supply.

Original languageEnglish (US)
Pages (from-to)6014-6020
Number of pages7
JournalACS Nano
Volume4
Issue number10
DOIs
StatePublished - Oct 26 2010
Externally publishedYes

Fingerprint

viruses
Viruses
delivery
Blood
Lighting
cancer
Cells
Singlet Oxygen
Photodynamic therapy
Bacteriophages
T-cells
Porphyrins
Pathogens
cells
Amino acids
DNA
blood
Amino Acids
Oxygen
illumination

Keywords

  • aptamers
  • photodynamic therapy
  • porphyrins
  • targeted delivery
  • viral capsids

ASJC Scopus subject areas

  • Engineering(all)
  • Materials Science(all)
  • Physics and Astronomy(all)

Cite this

Dual-surface modified virus capsids for targeted delivery of photodynamic agents to cancer cells. / Stephanopoulos, Nicholas; Tong, Gary J.; Hsiao, Sonny C.; Francis, Matthew B.

In: ACS Nano, Vol. 4, No. 10, 26.10.2010, p. 6014-6020.

Research output: Contribution to journalArticle

Stephanopoulos, Nicholas ; Tong, Gary J. ; Hsiao, Sonny C. ; Francis, Matthew B. / Dual-surface modified virus capsids for targeted delivery of photodynamic agents to cancer cells. In: ACS Nano. 2010 ; Vol. 4, No. 10. pp. 6014-6020.
@article{4d09a8270f2f4e79a966c80e8ba11549,
title = "Dual-surface modified virus capsids for targeted delivery of photodynamic agents to cancer cells",
abstract = "Bacteriophage MS2 was used to construct a targeted, multivalent photodynamic therapy vehicle for the treatment of Jurkat leukemia T cells. The self-assembling spherical virus capsid was modified on the interior surface with up to 180 porphyrins capable of generating cytotoxic singlet oxygen upon illumination. The exterior of the capsid was modified with ∼20 copies of a Jurkat-specific aptamer using an oxidative coupling reaction targeting an unnatural amino acid. The capsids were able to target and selectively kill more than 76{\%} of the Jurkat cells after only 20 min of illumination. Capsids modified with a control DNA strand did not target Jurkat cells, and capsids modified with the aptamer were found to be specific for Jurkat cells over U266 cells (a control B cell line). The doubly modified capsids were also able to kill Jurkat cells selectively even when mixed with erythrocytes, suggesting the possibility of using our system to target blood-borne cancers or other pathogens in the blood supply.",
keywords = "aptamers, photodynamic therapy, porphyrins, targeted delivery, viral capsids",
author = "Nicholas Stephanopoulos and Tong, {Gary J.} and Hsiao, {Sonny C.} and Francis, {Matthew B.}",
year = "2010",
month = "10",
day = "26",
doi = "10.1021/nn1014769",
language = "English (US)",
volume = "4",
pages = "6014--6020",
journal = "ACS Nano",
issn = "1936-0851",
publisher = "American Chemical Society",
number = "10",

}

TY - JOUR

T1 - Dual-surface modified virus capsids for targeted delivery of photodynamic agents to cancer cells

AU - Stephanopoulos, Nicholas

AU - Tong, Gary J.

AU - Hsiao, Sonny C.

AU - Francis, Matthew B.

PY - 2010/10/26

Y1 - 2010/10/26

N2 - Bacteriophage MS2 was used to construct a targeted, multivalent photodynamic therapy vehicle for the treatment of Jurkat leukemia T cells. The self-assembling spherical virus capsid was modified on the interior surface with up to 180 porphyrins capable of generating cytotoxic singlet oxygen upon illumination. The exterior of the capsid was modified with ∼20 copies of a Jurkat-specific aptamer using an oxidative coupling reaction targeting an unnatural amino acid. The capsids were able to target and selectively kill more than 76% of the Jurkat cells after only 20 min of illumination. Capsids modified with a control DNA strand did not target Jurkat cells, and capsids modified with the aptamer were found to be specific for Jurkat cells over U266 cells (a control B cell line). The doubly modified capsids were also able to kill Jurkat cells selectively even when mixed with erythrocytes, suggesting the possibility of using our system to target blood-borne cancers or other pathogens in the blood supply.

AB - Bacteriophage MS2 was used to construct a targeted, multivalent photodynamic therapy vehicle for the treatment of Jurkat leukemia T cells. The self-assembling spherical virus capsid was modified on the interior surface with up to 180 porphyrins capable of generating cytotoxic singlet oxygen upon illumination. The exterior of the capsid was modified with ∼20 copies of a Jurkat-specific aptamer using an oxidative coupling reaction targeting an unnatural amino acid. The capsids were able to target and selectively kill more than 76% of the Jurkat cells after only 20 min of illumination. Capsids modified with a control DNA strand did not target Jurkat cells, and capsids modified with the aptamer were found to be specific for Jurkat cells over U266 cells (a control B cell line). The doubly modified capsids were also able to kill Jurkat cells selectively even when mixed with erythrocytes, suggesting the possibility of using our system to target blood-borne cancers or other pathogens in the blood supply.

KW - aptamers

KW - photodynamic therapy

KW - porphyrins

KW - targeted delivery

KW - viral capsids

UR - http://www.scopus.com/inward/record.url?scp=78049334596&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78049334596&partnerID=8YFLogxK

U2 - 10.1021/nn1014769

DO - 10.1021/nn1014769

M3 - Article

C2 - 20863095

AN - SCOPUS:78049334596

VL - 4

SP - 6014

EP - 6020

JO - ACS Nano

JF - ACS Nano

SN - 1936-0851

IS - 10

ER -